AMR prevention
National Institute of Public Health ·Czechia
About this project
<p><span style="font-size: 10pt"><span style="font-family: "Calibri", "sans-serif"">The proposed project aims at prevention of inappropriate or unnecessary use of antibiotics. The planned activities are a reaction to the rise of antibiotic resistance, which is caused mainly by overuse and misuse of antibiotics in human and veterinary medicine, as well as by insufficient prevention measures and infection control facilitating the spread of resistant microbes in healthcare facilities and among general population. The main activity of the project will be social mass-media campaign aimed at general public. The aim of the activity is to increase awareness of general public about the risks of inappropriate use of antibiotics and build sustainable approach in the society to the wise use of antibiotics. The second part of the project is oriented towards health care providers. Guidelines for health care providers, mainly general practitioners and paediatricians, on rational use of antibiotics will be developed and introduced to health care providers at seminars across the Czech Republic. Based on data obtained from health insurance companies, the selected health care providers will be also offered feedback with regard to the use of antibiotics in their own practices. An increased level of awareness on importance of rational use of antibiotics and promotion of tailored treatment recommendations should contribute to the stop of increasing trends of antibiotic consumption in the Czech Republic.</span></span></p>
Bilateral cooperation results
The collaboration with the Norwegian partner has yielded several key results: (i) there has been successful knowledge and best practice sharing in the area of Antibiotic Prescription Recommendations. The Norwegian partner provided expertise in designing these recommendations to maximize their potential impact. (ii) participation in the KMINE conference, which gave the Czech side insight into best practices that could lead to more effective solutions to problems related to antimicrobial resistance, hospital infections, and ensuring uninterrupted supplies of antibiotics to the market. The collaboration demonstrated that the Norwegian partner's best practices can serve as a model for the Czech Republic. However, the COVID-19 pandemic limited opportunities for in-person meetings, which had a negative impact on the potential scope of the collaboration. Nonetheless, it became evident that personal interactions, such as the Norwegian partner's participation in the conference in Olomouc, represent significant added value for both parties and are crucial for sharing best practices in addressing this globally important threat.
Project partners
- Norwegian Institute of Public Health Donor project partner· Norway